TrialJournal of acquired immune deficiency syndromes (1999)2016

Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot Study.

Jan van Lunzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.